The ENKORE cluster is calling for immediate action to reduce our exposure to endocrine disruptors (EDs), as mounting evidence highlights their harmful impact on health. In our latest policy brief, we outline what science-based policy action we need to limit our exposure to these substances.
EDs are chemical substances — natural or synthetic — that can mimic, block, or interfere with the body’s hormones. Recent research links exposure to hormone-related cancers, cognitive changes, reproductive and metabolic disorders.
Endocrine disorders pose a significant societal and economic burden, according to ENKORE’s latest policy brief. In the EU alone, the estimated annual costs related to effects of exposure to EDs is €163 billion. Continuous exposure to EDs at low doses is inevitable since they occur in the environment, food, and a wide range of products in our daily lives. Policy action can make a difference in reducing our exposure.
Our brief advises policymakers on increasing efficiency in the regulatory evaluation of EDs, communicating effectively about the risks of exposure to EDs, and strengthening both EU and global regulation of EDs.
Read the full policy brief below or download it here: ENKORE policybrief: Protecting people from endocrine disruptors
